This article has been updated from a previous version to include additional comments from Cliff Reid regarding the expected cost of Complete's services.

By Edward Winnick

SAN FRANCISCO (GenomeWeb News) - Complete Genomics is on the cusp of launching its commercial operations and is aiming to sequence several thousand human genomes this year — and potentially up to a million human genomes over the next five years — company officials told investors Wednesday at the JP Morgan Healthcare Conference.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.